Infographic: Pivotal clinical trial costs
Clinical trials that support FDA approvals of new drugs have a median cost of $19m – representing less than one percent of the average drug development cost, which is estimated at between $2 and $3bn.
These numbers according to a team of researchers from Johns Hopkins Bloomberg School of Public Health who conducted an assessment of the costs of pivotal clinical trials.
Read: Clinical trial cost is a fraction of the drug development bill
The results were published this week in JAMA Internal Medicine.
